February 15, 2024
A New York federal judge has adopted in full a magistrate judge's recommendation to toss a suit accusing several broker-dealers, including Citadel Securities LLC and Virtu Americas LLC, of carrying out a spoofing scheme that repeatedly drove a biotechnology company's share price down, saying he agrees with the report's finding that the suit fails to show that the alleged scheme caused lower stock prices in every instance.
March 21, 2023
Several broker-dealers, including Citadel Securities LLC and Canaccord Genuity LLC, asked a New York federal judge on Monday to toss a suit accusing them of carrying out a spoofing scheme that repeatedly drove a biotechnology company's share price down, saying the case fails to allege any actionable trading or evidence of misconduct.
December 01, 2022
Northwest Biotherapeutics Inc. on Thursday sued several broker-dealers including Citadel Securities LLC and Canaccord Genuity LLC in New York federal court for allegedly carrying out a spoofing scheme that repeatedly drove the biotechnology company's share price down despite promising developments with a cancer drug.